+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
ID06052969

Early Feasibility Study of Pulse NanoMED Device for Treatment of Acute Ischemic Stroke After Mechanical Thrombectomy

Led by Euphrates Vascular, Inc. · Updated on 2025-08-07

8

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying an early feasibility trial involving adults who have experienced an acute ischemic stroke AIS and have undergone mechanical thrombectomy and intravenous thrombolytic therapy. The study focuses on patients with visible occlusive clots in specific brain arteries and aims to evaluate the Pulse NanoMED procedure to improve reperfusion after standard neurovascular treatment. Participants will receive the Pulse NanoMED System, which includes iron nanoparticles and a portable magnetic workstation, after attempted neurovascular therapy. This single-arm study enrolls subjects presenting with AIS and evidence of occlusive clots confirmed by angiographic imaging. The investigational device is applied post-thrombolytic therapy and mechanical thrombectomy to address residual occlusions. During the study, participants will be monitored at 24 hours, 7 days or discharge if earlier, 30 days, and 90 days after the procedure. Researchers will assess clinical outcomes related to reperfusion and safety measures. The total involvement includes multiple follow-up visits to evaluate how well the treatment works and to monitor for any adverse effects.

CONDITIONS

Brief Title

Pulse Endovascular ReperFUSION for Acute Ischemic Stroke

Research Team

K

Kristen Hlozek, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here